Radiation boosts immunotherapy in advanced cancers: early trial shows promise
NCT ID NCT04620603
First seen Nov 06, 2025 · Last updated May 23, 2026 · Updated 29 times
Summary
This early-phase study tested adding low-dose internal radiation (brachytherapy) to standard immunotherapy for people with advanced melanoma, kidney cancer, or urinary tract cancer. Only 5 participants were enrolled to see if the combination helps shrink tumors. The goal was to measure tumor response using standard criteria, but results are not yet available.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RENAL CELL CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Cleveland Clinic, Case Comprehensive Cancer Center
Cleveland, Ohio, 44122, United States
Conditions
Explore the condition pages connected to this study.